Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte

  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités

2 results

  • Active substance : alcool
  • Active substance : ritonavir
  • Topics : Infectious diseases
Filter
Topic
  • Diseases and conditions (2)
  • Plus ...
    • Infectious diseases (2)
    • Plus ...
      • Virus diseases (2)
      • Sexually transmitted diseases (1)
    • Digestive system diseases (2)
    • Plus ...
      • Liver diseases (2)
  • Economics and public health (1)
  • Plus ...
    • Organisation of care (1)
  • Diagnostic and therapeutic techniques (1)
  • Plus ...
    • Diagnostic techniques and procedures (1)
    • Plus ...
      • Biology (laboratory tests) (1)
Content type
  • Drugs, devices and medical acts (1)
  • Plus ...
    • Health technology assessment (1)
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Chronic disease guide (1)
Manufacturer
  • inconnu (1)
Language
  • Français (2)
Active substance
  • alanine (1)
  • alcool (2)
  • lamivudine (1)
  • ribavirine (1)
  • ritonavir (2)
 More filter Other Filter Icon
Search Export

Practice guidelines and other guides - 1 result

  • Chronic hepatitis C

    Chronic disease guide - Posted on 15/11/2024
    Add to my selection

Drugs, devices and medical acts - 1 result

  • Update of laboratory medicine procedures related to the diagnosis and management of hepatitis B, C and D - INAHTA Brief

    Health technology assessment - Posted on 16/1/2017
    Download document
    Add to my selection

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
J3M4YFFBdFVNBH9B